INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC., MAIA BIOTECHNOLOGY, INC. FILES APPLICATION FOR "TREATMENT OF NON-SMALL CELL LUNG CANCER WITH 6-THIO-DG AND CEMIPLIMAB"

GENEVA, May 6 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, NY 10591), MAIA BIOTECHNOLOGY, INC. (444 West Lake Street, Suite 1700Chicago, IL 60606) filed a patent application (PCT/US2024/052463) for "TREATMENT OF NON-SMALL CELL LUNG CANCER WITH 6-THIO-DG AND CEMIPLIMAB" on Oct 22, 2024. With publication no. WO/2025/090539, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VITOC, Vlad (c/o Maia Biotechnology, Inc.444 West Lake Street, Suite 1700Chicago, IL 60606), GRYAZNOV, Sergei (138 West Bellev...